Related Experiment Video
Updated: Mar 9, 2026

Reconstitution Of β-catenin Degradation In Xenopus Egg Extract
Published on: June 17, 2014
Epigenetic disruption of the WNT/ß-catenin signaling pathway in human cancers
Abstract:
Aberrant activation of the WNT/ß-catenin signaling pathway is frequently involved in a broad spectrum of human malignancies. Alternative to genetic deletions and point mutations, epigenetic inactivation of negative WNT regulators, through DNA methylation of promoter CpG islands and/or histone modification, leads to the activation or amplification of aberrant WNT/ß-catenin signaling. In this review, we summarized the contribution of epigenetic dysregulation of WNT/ß-catenin signaling to tumorigenesis and highlighted the importance of epigenetic identification of negative regulators of this pathway as putative tumor suppressors. The reversal of these silenced regulators may be developed as potential cancer therapeutics.
Insights
Epigenetic silencing of WNT pathway regulators promotes cancer. Identifying and reversing these epigenetic changes offers potential new cancer therapies targeting WNT/ß-catenin signaling.
Area of Science:
- Molecular Oncology
- Epigenetics
- Cancer Biology
Background:
- Aberrant WNT/ß-catenin signaling is a hallmark of many human cancers.
- Epigenetic mechanisms, including DNA methylation and histone modification, can inactivate tumor suppressors.
- This pathway's dysregulation is crucial for tumorigenesis.
Purpose of the Study:
- To review the role of epigenetic dysregulation in WNT/ß-catenin signaling in cancer.
- To highlight negative WNT regulators as potential tumor suppressors.
- To explore therapeutic strategies targeting epigenetic silencing.
Main Methods:
- Literature review of epigenetic mechanisms affecting WNT signaling.
- Analysis of studies linking epigenetic modifications to WNT pathway activation.
- Identification of key negative WNT regulators implicated in cancer.
Main Results:
- Epigenetic inactivation of WNT negative regulators contributes to cancer development.
- DNA methylation and histone modifications are key mechanisms of silencing.
- These silenced regulators act as tumor suppressors.
Conclusions:
- Epigenetic dysregulation of the WNT/ß-catenin pathway is a significant driver of human malignancies.
- Epigenetic identification of silenced WNT regulators is crucial for understanding tumorigenesis.
- Reversing epigenetic silencing presents a promising therapeutic avenue for cancer treatment.
Related Concept Videos
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

